Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02899793
Brief Title: Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer

First Submitted : September 9, 2016
First Submitted that Met QC Criteria : September 9, 2016
First Posted : September 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 16, 2021
Last Update Posted : April 19, 2021